- Home
- EQR vs PHG Comparison
EQR vs PHG Comparison
Compare EQR & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQR | PHG |
|---|---|---|
| Founded | 1993 | 1891 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Electronics |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 26.8B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | EQR | PHG |
|---|---|---|
| Price | $61.50 | $27.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $70.00 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 651.5K |
| Earning Date | 10-28-2025 | 11-04-2025 |
| Dividend Yield | ★ 4.54% | 3.04% |
| EPS Growth | ★ 24.49 | N/A |
| EPS | ★ 3.03 | 0.21 |
| Revenue | $3,078,827,000.00 | ★ $20,861,199,111.00 |
| Revenue This Year | $5.06 | $0.72 |
| Revenue Next Year | $3.55 | $3.11 |
| P/E Ratio | ★ $20.13 | $132.98 |
| Revenue Growth | ★ 4.69 | N/A |
| 52 Week Low | $58.38 | $21.48 |
| 52 Week High | $75.86 | $29.54 |
Technical Indicators
Market Signals| Indicator | EQR | PHG |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 42.53 |
| Support Level | $61.02 | $26.30 |
| Resistance Level | $62.42 | $28.32 |
| Average True Range (ATR) | 0.90 | 0.36 |
| MACD | 0.26 | -0.09 |
| Stochastic Oscillator | 62.17 | 32.53 |
Price Performance
Historical ComparisonAbout EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About PHG Koninklijke Philips N.V. NY Registry Shares
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.